← All candidates
Three insider buys in the last year — $8.54M in all.
36 filings on record.
PMNProMIS Neurosciences Inc.
NasdaqCM · Healthcare · $121.60M
$13.56
+1.19% · Sep 11
Three insider buys in the last year — $8.54M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 3 buys◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what PMN ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$121.60M
Float
4.4M
49% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
ABG Management Ltd.
Bought $8.50M on Feb 3 — 700,741 sh @ $12.13, held indirect, 74% of their stake.
0 of 1 position beat the S&P
Chief Development Officer
Kaplan Johanne
Bought $25.0K on Feb 19 — 1,629 sh @ $15.35, held direct, 41% of their stake.
0 of 1 position beat the S&P
Insider
Milbury Max A.
Bought $14.9K on Oct 3 — 30,392 sh @ $0.4912, held direct, 67% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
17 more transactions on Pro →The file stays open
36 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice